Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection

NCT02166502 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT02166502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02166502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection
Lead sponsor
The Hospital for Sick Children
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
November 30, 2015
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, human immunodeficiency virus, vertical infection transmission